Wells Fargo & Company Lowers Kimberly-Clark (NASDAQ:KMB) Price Target to $105.00

Kimberly-Clark (NASDAQ:KMB) had its target price dropped by equities research analysts at Wells Fargo & Company from $110.00 to $105.00 in a note issued to investors on Thursday, Benzinga reports. The firm presently has an “equal weight” rating on the stock. Wells Fargo & Company‘s price objective points to a potential upside of 6.57% from the company’s current price.

A number of other research firms have also issued reports on KMB. Freedom Capital raised shares of Kimberly-Clark from a “hold” rating to a “strong-buy” rating in a report on Tuesday, August 4th. Weiss Ratings raised shares of Kimberly-Clark from a “hold (c-)” rating to a “hold (c)” rating in a research note on Tuesday, July 28th. UBS Group upped their price objective on shares of Kimberly-Clark from $115.00 to $116.00 and gave the company a “neutral” rating in a research note on Wednesday, August 5th. TD Cowen increased their price objective on shares of Kimberly-Clark from $96.00 to $104.00 and gave the company a “hold” rating in a report on Wednesday, August 5th. Finally, Seaport Research Partners raised shares of Kimberly-Clark to a “buy” rating in a research note on Tuesday, August 4th. One analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, eleven have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $117.57.

Kimberly-Clark Price Performance

KMB stock traded down $0.17 during trading on Thursday, hitting $98.53. The stock had a trading volume of 5,113,851 shares, compared to its average volume of 4,821,960. The company has a debt-to-equity ratio of 3.45, a current ratio of 0.91 and a quick ratio of 0.69. Kimberly-Clark has a twelve month low of $92.42 and a twelve month high of $130.02. The stock has a market capitalization of $32.77 billion, a P/E ratio of 16.75, a PEG ratio of 4.30 and a beta of 0.25. The company’s 50-day moving average price is $109.34 and its two-hundred day moving average price is $103.55.

Kimberly-Clark (NASDAQ:KMB) last released its earnings results on Tuesday, August 4th. The company reported $1.80 earnings per share for the quarter, missing the consensus estimate of $2.01 by ($0.21). Kimberly-Clark had a net margin of 11.79% and a return on equity of 143.92%. The firm had revenue of $4.19 billion during the quarter, compared to analysts’ expectations of $4.22 billion. During the same quarter last year, the business earned $1.92 EPS. The business’s revenue was up .6% compared to the same quarter last year. As a group, research analysts predict that Kimberly-Clark will post 7.43 EPS for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the business. Darwin Wealth Management LLC acquired a new position in Kimberly-Clark in the 2nd quarter valued at $27,000. Godfrey Financial Associates Inc. bought a new stake in shares of Kimberly-Clark in the 4th quarter worth approximately $25,000. CrossGen Wealth LLC bought a new position in shares of Kimberly-Clark during the 4th quarter worth about $27,000. Ancora Advisors LLC acquired a new position in Kimberly-Clark in the second quarter worth about $32,000. Finally, Edmond DE Rothschild Holding S.A. bought a new position in Kimberly-Clark during the 2nd quarter valued at about $32,000. Institutional investors and hedge funds own 76.29% of the company’s stock.

Kimberly-Clark Company Profile

Kimberly-Clark Corporation is a global manufacturer of personal care and consumer tissue products. The company develops and markets products designed to support personal hygiene, health and well-being in households, healthcare settings and workplaces.

Its portfolio includes well-known brands such as Huggies diapers and training pants, Kleenex facial tissues, Cottonelle toilet paper and wipes, Scott toilet paper and paper towels, Kotex feminine care products, and Depend and Poise incontinence care products.